Improved Overall Survival in Patients with Lung Cancer and Autoimmune Rheumatic Diseases

Multidisciplinary collaboration is crucial for rheumatologist Laura Cappelli. Her recent study, conducted with Johns Hopkins oncologists, showed that patients with both an rheumatic disease and lung cancer who were diagnosed earlier had better survival outcomes compared to patients without such rheumatic conditions. Cappelli discussed her research in advance of a presentation at the American College of Rheumatology / Association of Rheumatology Professionals 2022 annual conference.

Related Presenters

Laura Cappelli, M.D..

Laura Cappelli, M.D.

Assistant Professor of Medicine

Dr. Laura Cappelli is an Assistant Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli ...

View full profile


Related Videos